Skip to content
2000
Volume 16, Issue 16
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Coxibs are a class of powerful drugs used by millions of people worldwide to treat a wide variety of ailments such as muscular skeletal pain and inflammation. The primary mechanism of action of coxibs is the potent inhibition of the COX-2 enzyme. Unfortunately, their use is limited to patients due to a variety of factors including poor solubility, negative effects on renal clearance and increased risk of cardiovascular pathology. However, because of their effectiveness in blocking PGE2 mediated inflammation, a key pathway that drives many diseases, there is a clear unmet medical need to develop new COX-2 inhibitors that are free of the aforementioned problems. The purpose of this prospectus is to define the specific properties that are desired in 3rd generation coxibs as a starting point for the development of new and better drugs.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557515666160509125702
2016-11-01
2025-09-08
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557515666160509125702
Loading

  • Article Type:
    Research Article
Keyword(s): Cancer; COX-2; Inflammation; Pain; PGE2
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test